Chloroprocaine
Clorotekal, Iheezo, Nesacaine, Nesacaine-mpf (chloroprocaine) is a small molecule pharmaceutical. Chloroprocaine was first approved as Nesacaine on 1982-01-01. It is used to treat pain in the USA. It is known to target ryanodine receptor 1 and ryanodine receptor 2.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
Clorotekal, Iheezo, Nesacaine, Nesacaine-mpf (generic drugs available since 1998-09-09)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Chloroprocaine hydrochloride
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
clorotekal | New Drug Application | 2020-12-04 |
iheezo | New Drug Application | 2022-09-27 |
nesacaine | New Drug Application | 2022-12-29 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
pain | EFO_0003843 | D010146 | R52 |
Agency Specific
FDA
EMA
Expiration | Code | ||
---|---|---|---|
CHLOROPROCAINE HYDROCHLORIDE, IHEEZO, HARROW EYE | |||
2025-09-27 | NP |
HCPCS
Code | Description |
---|---|
J2400 | Injection, chloroprocaine hydrochloride, per 30 ml |
Clinical
Clinical Trials
38 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cough | D003371 | HP_0012735 | R05 | 1 | — | 2 | — | 1 | 4 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neuralgia | D009437 | EFO_0009430 | — | 1 | — | — | — | 1 | |
Hiv infections | D015658 | EFO_0000764 | B20 | — | 1 | — | — | — | 1 |
Sinusitis | D012852 | EFO_0007486 | J32 | — | 1 | — | — | — | 1 |
Common cold | D003139 | EFO_0007214 | J00 | — | 1 | — | — | — | 1 |
Communicable diseases | D003141 | — | 1 | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pneumonia | D011014 | EFO_0003106 | J18 | — | — | — | — | 1 | 1 |
Lung diseases | D008171 | EFO_0003818 | J98.4 | — | — | — | — | 1 | 1 |
Pulmonary fibrosis | D011658 | J84.10 | — | — | — | — | 1 | 1 | |
Back pain | D001416 | HP_0003418 | M54 | — | — | — | — | 1 | 1 |
Infections | D007239 | EFO_0000544 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | CHLOROPROCAINE |
INN | chloroprocaine |
Description | Chloroprocaine is procaine in which one of the hydrogens ortho- to the carboxylic acid group is substituted by chlorine. It is used as its monohydrochloride salt as a local anaesthetic, particularly for oral surgery. It has the advantage over lidocaine of constricting blood vessels, so reducing bleeding. It has a role as a local anaesthetic, a peripheral nervous system drug and a central nervous system depressant. It is a benzoate ester and a member of monochlorobenzenes. It is functionally related to a 2-diethylaminoethanol and a 4-amino-2-chlorobenzoic acid. |
Classification | Small molecule |
Drug class | local anesthetics |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCN(CC)CCOC(=O)c1ccc(N)cc1Cl |
Identifiers
PDB | — |
CAS-ID | 133-16-4 |
RxCUI | 20859 |
ChEMBL ID | CHEMBL1179047 |
ChEBI ID | 3636 |
PubChem CID | 8612 |
DrugBank | DB01161 |
UNII ID | 5YVB0POT2H (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
RYR1
RYR1
RYR2
RYR2
Organism
Homo sapiens
Gene name
RYR1
Gene synonyms
RYDR
NCBI Gene ID
Protein name
ryanodine receptor 1
Protein synonyms
central core disease of muscle, protein phosphatase 1, regulatory subunit 137, ryanodine receptor 1 (skeletal), sarcoplasmic reticulum calcium release channel, Skeletal muscle calcium release channel, Skeletal muscle ryanodine receptor, Skeletal muscle-type ryanodine receptor, Type 1 ryanodine receptor, type 1-like ryanodine receptor
Uniprot ID
Mouse ortholog
Ryr1 (20190)
ryanodine receptor 1 (Q99JF9)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 391 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
17 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more